Grants and Contributions:

Back to search

Title:

Detection and analysis of neovascularization in retinal fundus images

Agreement Number:

980878

Agreement Value:

$41,000.00

Agreement Date:

Oct 1, 2021 - Sep 30, 2022

Description:

According to Health Canada, in 2019, about 11% of Canadians aged 20 and over were living with diabetes, and the rate has been increasing. Diabetes causes damage to blood vessels and leads to diabetic retinopathy (DR), ultimately leading to the growth of new vessels, called neovascularization (NV). NV can lead to retinal damage or separation, especially when the new vessels rupture. Presence of untreated NV is associated with loss of vision. In this project, the Firm proposes to develop digital image processing and machine learning techniques to detect, characterize, and analyze vascular patterns related to neovascularization and outcomes are expected to assist ophthalmologists in performing timely diagnosis and follow-up of patients with advanced DR.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Calgary, Alberta, CA T3H 5M3

Reference Number:

172-2021-2022-Q3-980878

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

724516687

Recipient Type:

For-profit organization

Recipient's Operating Name:

Aurteen Inc.

Recipient's Legal Name:

Aurteen Inc.

Federal Riding Name:

Calgary Signal Hill

Federal Riding Number:

48012

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

51121